{"id":49348,"date":"2022-10-07T12:01:54","date_gmt":"2022-10-07T10:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/microbiome-therapeutics-global-market-report-2022-rising-prevalence-of-obesity-expected-to-propel-sector-growth-researchandmarkets-com\/"},"modified":"2022-10-07T12:01:54","modified_gmt":"2022-10-07T10:01:54","slug":"microbiome-therapeutics-global-market-report-2022-rising-prevalence-of-obesity-expected-to-propel-sector-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/microbiome-therapeutics-global-market-report-2022-rising-prevalence-of-obesity-expected-to-propel-sector-growth-researchandmarkets-com\/","title":{"rendered":"Microbiome Therapeutics Global Market Report 2022: Rising Prevalence of Obesity Expected to Propel Sector Growth – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Microbiome Therapeutics Global Market Report 2022”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global microbiome therapeutics market is expected to grow from $0.29 billion in 2021 to $0.39 billion in 2022 at a compound annual growth rate (CAGR) of 34.7%. The microbiome therapeutics market is expected to grow to $1 billion in 2026 at a compound annual growth rate (CAGR) of 26.4%.\n<\/p>\n

\nThe rising prevalence of obesity is expected to propel the growth of the microbiome therapeutics market. Sedentary lifestyles, busy work lives, and unhealthy food choices are gradually becoming the leading causes of obesity globally. Growing urbanization and busy lifestyles are leading to an increasing preference for packaged and processed food and physical inactivity. Microbiome therapeutics help prevents and treats diabetes by regulating sugar levels.\n<\/p>\n

\nFor instance, in 2022, according to UK Parliament, a survey found that men are more likely than women to be overweight or obese (68.2% of men, 60.4% of women). People aged 45-74 are most likely to be overweight or obese. Therefore, the rising prevalence of obesity is driving the growth of microbiome therapeutics.\n<\/p>\n

\nIncreased research and development are a key trend gaining popularity in the microbiome therapeutics market. Companies operating in the microbiome therapeutics market are focused on developing new innovations to increase their market share. For instance, in March 2022, Microbiotica, a UK-based company raised $67 million in a Series B round to push two microbiome-based lead assets through phase 1b trials, slated to start this year.\n<\/p>\n

\nIn April 2022, Xbiome Inc, a China-based artificial intelligence microbiome therapeutics startup acquired a clinical-stage M201 program from Assembly Biosciences, Inc for an undisclosed amount. This acquisition reflects Xbiome’s commitment as one of the leaders in the rising field of microbiome therapeutics. Assembly Biosciences Inc is a US-based clinical-stage biotechnology company.\n<\/p>\n

\nScope<\/strong>\n<\/p>\n

\nMarkets Covered:<\/strong>\n<\/p>\n

\n1) By Product: Probiotics; Prebiotics; Symbiotics; Other Products\n<\/p>\n

\n2) By Application: Inflammatory Bowel Disease; Diabetes; Multiple Sclerosis; Rheumatoid Arthritis; Other Applications\n<\/p>\n

\n3) By Distribution Channel: Hospital Pharmacies; Drug stores; Retail Pharmacies; E-commerce stores Companies Mentioned: Qualcomm, Intel Corporation, Ericsson, Samsung, AT&T\n<\/p>\n

\nKey Topics Covered:<\/strong>\n<\/p>\n

\n1. Executive Summary<\/strong>\n<\/p>\n

\n2. Microbiome Therapeutics Market Characteristics<\/strong>\n<\/p>\n

\n3. Microbiome Therapeutics Market Size And Growth<\/strong>\n<\/p>\n

\n4. Microbiome Therapeutics Market Segmentation<\/strong>\n<\/p>\n

\n5. Microbiome Therapeutics Market Regional And Country Analysis<\/strong>\n<\/p>\n

\n6. Asia-Pacific Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n7. China Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n8. India Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n9. Japan Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n10. Australia Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n11. Indonesia Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n12. South Korea Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n13. Western Europe Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n14. UK Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n15. Germany Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n16. France Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n17. Eastern Europe Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n18. Russia Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n19. North America Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n20. USA Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n21. South America Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n22. Brazil Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n23. Middle East Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n24. Africa Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n25. Microbiome Therapeutics Market Competitive Landscape And Company Profiles<\/strong>\n<\/p>\n

\n26. Key Mergers And Acquisitions In The Microbiome Therapeutics Market<\/strong>\n<\/p>\n

\n27. Microbiome Therapeutics Market Trends And Strategies<\/strong>\n<\/p>\n

\n28. Microbiome Therapeutics Market Future Outlook and Potential Analysis<\/strong>\n<\/p>\n

\n29. Appendix<\/strong>\n<\/p>\n

\nCompanies Mentioned<\/strong>\n<\/p>\n